Back
Edap TMS SA Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
19
EDAP
Edap TMS SA
Last Price:
3.05
Seasonality Move:
1.55%
Sell
23
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.01
Seasonality Move:
-31.44%
Sell
19
Edap TMS SA (EDAP)
is a Sell
Is Edap TMS SA a Buy, Sell or Hold?
- The current Edap TMS SA [EDAP] share price is $3.08. The Score for EDAP is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- EDAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
23
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.04. The Score for ADAP is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EDAP Stock Price Chart
What is Edap TMS SA's stock price today?
-
The Edap TMS SA share price today is $3.08
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDAP is experiencing slight selling pressure.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $1.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight selling pressure.
EDAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.3 | Sell |
| Relative Strength Index (14 RSI): | 33.21 | Sell |
| Chaikin Money Flow: | -1554 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.02 - 4) | Sell |
| Bollinger Bands (100): | (3.86 - 6.26) | Sell |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 40.8 | Sell |
| Chaikin Money Flow: | -191017 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.06 - 1.22) | Sell |
| Bollinger Bands (100): | (0.99 - 1.23) | Sell |
EDAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.18 | Sell |
| 20-day SMA: | 3.33 | Sell |
| 50-day SMA: | 4.16 | Sell |
| 200-day SMA: | 5.75 | Sell |
| 8-day EMA: | 3.19 | Sell |
| 20-day EMA: | 3.41 | Sell |
| 50-day EMA: | 4.05 | Sell |
| 200-day EMA: | 5.62 | Sell |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.08 | Sell |
| 20-day SMA: | 1.16 | Sell |
| 50-day SMA: | 1.16 | Sell |
| 200-day SMA: | 1.09 | Sell |
| 8-day EMA: | 1.08 | Sell |
| 20-day EMA: | 1.12 | Sell |
| 50-day EMA: | 1.13 | Sell |
| 200-day EMA: | 1.1 | Sell |
Edap TMS SA Earnings Growth & EDAP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.09 per share, and an increase next year of $0.06 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.
Edap TMS SA Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||